These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3663959)

  • 21. Oestrogen receptors and primary breast cancer.
    Humeniuk V; Hawkins RA; Prescott RJ; Roberts MM; Stewart HJ; Forrest AP
    Aust N Z J Surg; 1982 Aug; 52(4):408-14. PubMed ID: 6956318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence dynamics does not depend on the recurrence site.
    Demicheli R; Biganzoli E; Boracchi P; Greco M; Retsky MW
    Breast Cancer Res; 2008; 10(5):R83. PubMed ID: 18844974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand.
    McNee RK; Mason BH; Neave LM; Kay RG
    Breast Cancer Res Treat; 1987; 9(2):145-50. PubMed ID: 3620716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Birth seasonality of breast cancer patients and its variation according to menopausal status and histologic type in Japan.
    Nakao H
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1105-10. PubMed ID: 3780816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns and predictors of first and subsequent recurrence in women with early breast cancer.
    Geurts YM; Witteveen A; Bretveld R; Poortmans PM; Sonke GS; Strobbe LJA; Siesling S
    Breast Cancer Res Treat; 2017 Oct; 165(3):709-720. PubMed ID: 28677011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and clinical features of breast cancer in the Auckland region.
    Newman PD; Mason BH; Holdaway IM; Kay RG; Arthur JF; Hitchcock GC
    N Z Med J; 1992 Apr; 105(931):117-20. PubMed ID: 1313956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence dynamics of breast cancer according to baseline body mass index.
    Biganzoli E; Desmedt C; Fornili M; de Azambuja E; Cornez N; Ries F; Closon-Dejardin MT; Kerger J; Focan C; Di Leo A; Nogaret JM; Sotiriou C; Piccart M; Demicheli R
    Eur J Cancer; 2017 Dec; 87():10-20. PubMed ID: 29096156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is season a prognostic factor in breast cancer?
    Mutlu H; Akca Z; Cihan YB; Kurnaz F; Aslan T; Erden A; Ugur H; Aksahin A; Buyukcelik A
    Asian Pac J Cancer Prev; 2013; 14(2):743-6. PubMed ID: 23621230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
    Fisher B; Jeong JH; Bryant J; Anderson S; Dignam J; Fisher ER; Wolmark N;
    Lancet; 2004 Sep 4-10; 364(9437):858-68. PubMed ID: 15351193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis.
    Krausz T; Jenkins D; Grontoft O; Pollock DJ; Azzopardi JG
    Histopathology; 1989 Jan; 14(1):25-36. PubMed ID: 2925177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid-hormone receptors and survival after first relapse in breast cancer.
    Howell A; Barnes DM; Harland RN; Redford J; Bramwell VH; Wilkinson MJ; Swindell R; Crowther D; Sellwood RA
    Lancet; 1984 Mar; 1(8377):588-91. PubMed ID: 6142305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oestrogen receptors and prognosis in early breast cancer.
    Cooke T; George D; Shields R; Maynard P; Griffiths K
    Lancet; 1979 May; 1(8124):995-7. PubMed ID: 86771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 Sep; 352(9132):930-42. PubMed ID: 9752815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancer.
    Kamby C; Andersen J; Ejlertsen B; Birkler NE; Rytter L; Zedeler K; Rose C
    Acta Oncol; 1991; 30(3):301-8. PubMed ID: 2036238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers?
    de Munck L; Siesling S; Bart J; Menke-Pluijmers MB; Otter R; Willemse PH
    Eur J Cancer Prev; 2013 Sep; 22(5):398-403. PubMed ID: 23492953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The profile of breast cancer in Western Australia.
    Chleboun JO; Gray BN
    Med J Aust; 1987 Oct; 147(7):331-4. PubMed ID: 3657657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.
    Lee ES; Han W; Kim MK; Kim J; Yoo TK; Lee MH; Lee KH; Kim TY; Moon HG; Im SA; Noh DY; Lee ES
    BMC Cancer; 2016 Jul; 16():430. PubMed ID: 27388210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of axillary recurrence after conservative breast surgery.
    Fredriksson I; Liljegren G; Arnesson LG; Emdin SO; Palm-Sjövall M; Fornander T; Holmqvist M; Holmberg L; Frisell J
    Br J Surg; 2002 Jul; 89(7):902-8. PubMed ID: 12081741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype.
    Braunstein LZ; Niemierko A; Shenouda MN; Truong L; Sadek BT; Abi Raad R; Wong JS; Punglia RS; Taghian AG; Bellon JR
    Breast J; 2015; 21(2):161-7. PubMed ID: 25559656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.